TFRI's 10th Scientific Meeting brings cancer researchers, patients and oncologists from across Canada to Toronto
![](/images/default-source/news-images/10sm_groupshot.tmb-0.jpeg?Culture=en&sfvrsn=2852f2f1_1)
The Terry Fox Research Institute’s 10th Scientific Meeting, titled Accelerating Collaborations in Cancer Research, was held on May 24-26 in Toronto.
Nearly 300 delegates, including cancer patients, survivors and caregivers and researchers from projects funded through TFRI’s three main research programs – the TFRI Research Grants Program, the Marathon of Hope Cancer Centres Network (MOHCCN) and the Digital Health and Discovery Platform (DHDP) – attended the event.
The meeting’s scientific program featured presentations from principal investigators and trainees from several TFRI-funded research teams, a demonstration of the DHDP, a tribute to stem cell pioneer Dr. Connie Eaves and exciting panel and discussions about the importance of about data sharing and the economics of precision medicine, among others. A Terry Fox Run led by Darrell Fox was also held, along with a gala dinner that included a tribute to Dr. Christopher Paige, who is stepping down as chair of TFRI’s Board, and a celebration of the Marathon of Hope Cancer Centres Network, which reached an exciting milestone of 5,000 cases profiled as part of its Gold Cohort.
“Witnessing the groundbreaking research presented and observing the collaborative discussions between researchers, cancer patients, oncologists and administrators was truly inspiring,” says Dr. Jim Woodgett, TFRI President and Scientific Director. “The 10th Scientific Meeting served as an excellent reminder of one of Terry Fox's most important messages: that we are all a part of the Marathon of Hope and that we must all work together to find new ways to end cancer through research.”
Following the meeting, more than one hundred cancer researchers signed an open letter, published in the Globe and Mail, calling for accelerated collaborations between patients, researchers, oncologists and fundraisers across Canada to help accelerate Terry Fox’s goal of finding better ways to prevent, detect, diagnose and treat cancers through research.
![](/images/default-source/news-images/10sm_groupshot.jpeg?sfvrsn=2852f2f1_1)
Rapid-Fire, Poster Session and Patients’ Choice Awards winners
The 10SM Organizing Committee would like to congratulate all the trainees who presented posters and rapid-fire talks. These individuals are the future of cancer research and an invaluable part of our research community.
The following trainees received awards at the 10SM:
Rapid-Fire Talks
First place: Sumaiyah Rehman (Princess Margaret Cancer Centre, University Health Network, Toronto) for Deciphering the role of drug tolerant persisters in cancer relapse
Second place: Gibran Edun (Princess Margaret Cancer Centre, University Health Network, Toronto) for IRF5 defines a new high-risk inflammatory T-lineage acute lymphoblastic leukemia subtype\
Third place: Khadjah AL Shankati (Princess Margaret Cancer Consortium [PM2C], Toronto) for Comprehensive whole genome and transcriptome analysis of advanced solid tumour patients treated with immune checkpoint inhibitor therapy in the pan-cancer cohorts from the Marathon of Hope Cancer Centres Network (MOHCCN) study
Poster Sessions
First place: Matt Waas (Princess Margaret Cancer Centre, University Health Network, Toronto) for Droplet based proteomics reveals CD36 as a marker for progenitors in mammary basal epithelium
Second place: Bianca Bossé (CHUM Research Centre, Montreal) for Characterization of escape mechanisms from FOLFIRINOX-induced senescence of pancreatic tumour cells
Third place: Jasper Wong for (Centre for Lymphoid Cancer, BC Cancer, Vancouver) Plasmablastic lymphoma (PBL) does not rely on B cell receptor signalling for survival
MOHCCN Patients’ Choice Awards
Members of the MOHCCN Patient Working Group also evaluated MOHCCN trainees on their ability to present their science to a lay audience. The winners of the first-ever MOHCCN Patients’ Choice Awards went to:
First place: Holly Lee (Arnie Charbonneau Cancer Institute, University of Calgary) for Mechanisms of resistance to T-Cell immunotherapies in multiple myeloma
Second place: Tayah Sommer (Department of Biology, University of Prince Edward Island) for Metabolic differences across breast cancer tumours
Third place: Marie-Claire Wasson (Department of Pathology, Faculty of Medicine, Dalhousie University, Halifax) for Profiling the transcriptome to identify novel genetic mediators of breast tumour immune suppression
Related News
-
Our Network reaches new heights! A letter from Dr. André Veillette
Dr. André Veillette, Executive Director of the MOHCCN, provides an update on the exciting achievement from across our Network. -
Network names four outstanding early-career clinician-scientists as recipients of its 2024 MOHCCN Clinician-Scientist Awards
Four promising, early-career clinician-scientists from Alberta, Ontario and Quebec have been named recipients of the 2024 Clinician-Scientist Awards, funded by the Marathon of Hope Cancer Centres Netw... -
Network names 10 early-career data scientists as recipients of its 2024 Health Informatics & Data Science Awards
Each will receive $40,000 from the Network over the next year to be matched by their host institutions for a total of $80,000 to support groundbreaking research in precision oncology. -
Marathon of Hope Cancer Centres Network and Canadian Cancer Trials Group partner on three pan-Canadian projects aimed at making immunotherapy more effective for cancer patients
A new partnership between the Marathon of Hope Cancer Centres Network (MOHCCN) and the Canadian Clinical Trials Group (CCTG) will support three pan-Canadian research teams aiming to better understand ...